Biome Grow Inc.
Biome Grow Inc.
Your view on BIOIF
Overview
What the company does, where it operates, and who runs it.
About Biome Grow Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Khurram Malik
- Headquarters
- 1401-480 University Avenue, Toronto, ON, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Khurram Malik
- Headquarters
- 1401-480 University Avenue, Toronto, ON, CA
Biome Grow Inc. focuses on the cannabis business. The company is headquartered in Toronto, Canada.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
Fair value for Biome Grow Inc. from FRC's valuation model, read against the market price. BIOIF last traded at $0.0005; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Biome Grow Inc.. Starting points for Biome Grow Inc.: EPS -$0.10, beta -1.52 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Biome Grow Inc.. Biome Grow Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Biome Grow Inc.. Trailing twelve-month EPS for Biome Grow Inc. stands at -$0.10. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings Estimate
| EPS | Current QtrSep 2019 | Next QtrDec 2019 | Current YearFY Dec 2023 | Next YearFY Dec 2025 |
|---|---|---|---|---|
| Avg. estimate | CAD 0.00 | CAD 0.00 | CAD 0.19 | -CAD 0.03 |
| Low estimate | CAD 0.00 | CAD 0.00 | CAD 0.19 | -CAD 0.03 |
| High estimate | CAD 0.00 | CAD 0.00 | CAD 0.19 | -CAD 0.03 |
| No. of analysts | 0 | 0 | 1 | 1 |
| Year-ago EPS | — | — | -CAD 0.10 | — |
| Growth | — | — | +296.3% | — |
Revenue Estimate
| Revenue | Current QtrSep 2019 | Next QtrDec 2019 | Current YearFY Dec 2023 | Next YearFY Dec 2025 |
|---|---|---|---|---|
| Avg. estimate | CAD 3.04M | CAD 6.62M | CAD 276.88M | CAD 0.00 |
| Low estimate | CAD 3.04M | CAD 6.62M | CAD 276.88M | CAD 0.00 |
| High estimate | CAD 3.04M | CAD 6.62M | CAD 276.88M | CAD 0.00 |
| No. of analysts | 1 | 1 | 1 | 0 |
| Year-ago revenue | — | — | CAD 0.00 | — |
| Growth | — | — | — | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 12, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Biome Grow Inc.. Biome Grow Inc. has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Biome Grow Inc. valued side by side against its closest peers. Biome Grow Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Biome Grow Inc.. Coverage tracks Biome Grow Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Biome Grow Inc.